Feature Channels:

OBGYN

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Urinary Tract Infections, standard culture, Antibiotics, Bacteria, E. Coli, enhanced quantitative urine culture , EQUC, UTI

Enhanced Test for Urinary Tract Infections Detects More Bacteria Than Standard Test

One of the primary ways physicians diagnose urinary tract infections is with a test that detects bacteria in urine. A new enhanced test detects significantly more bacteria than the standard test, according to a study presented at a meeting of the American Society for Microbiology in New Orleans.

Medicine

Channels:

TNBC, Yale Cancer Center, Breast Cancer, immune therapy, durvalumab/MEDI4736

Immunotherapy Combination Shows Promise in Early Stage Triple Negative Breast Cancer

TNBC2.jpg

Immune checkpoint inhibitor (durvalumab/MEDI4736) with chemotherapy as a preoperative treatment shows promise in early stage TNBC.

Medicine

Channels:

Men's Health, men's health month, Men and alcohol, men and cancer, Men And Doctor Appointments, Men And Hypertension, Men And Skin Cancer, Skin Cancer, Prostate Cancer, Kidney Stone, Diet, Nutrition, Tobacco, Urology, Pulmonary, Memory Disorders, Vitamins

Men: Start Your Path to a Healthier You with 7 Tips

Mens-Health-7-ways-to-get-healthy-graphic.jpg

Physicians at UAB share tips on men’s health and how it affects heart health, sexual function and memory and decreases cancer risk.

Medicine

Channels:

Breast Cancer, Cancer Recurrence, Clinical Trial, Breast Cancer Recurrence, abramson cancer center, Penn Medicine

Slaying the Sleeping Dragon: Researchers Take Action Against Breast Cancer Recurrence

Medicine

Channels:

Genetic Testing, Yale Cancer Center, Cancer Prevention, Breast Cancer, minorities and computer science

Minority Breast Cancer Patients Less Likely to Have Genetic Test

gross.jpg

A genetic test that helps doctors determine how best to treat breast cancer—and whether chemotherapy is likely to help—is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found.

Medicine

Channels:

Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, Autism, Environmental Medicine, Public Health, Autism Spectrum Disorder

Exposure to Specific Toxins and Nutrients During Late Pregnancy and Early Life Correlated with Autism Risk

Mount Sinai study uses a unique source—baby teeth—to reveal that both the timing and amount of exposure can affect diagnosis

Medicine

Channels:

BRCA, Breast Cancer, American Cancer Society, Yale Cancer Center

Yale Cancer Center Researcher Receives Funding From the American Cancer Society for Research Into BRCA2

Medicine

Channels:

Human Papilloma Virus (Hpv), Hpv Vaccine, Yale Cancer Center, Cervical Cancer, CDC

Precancerous Lesions Associated with HPV Dropping in Connecticut, YSPH Study Finds

HPVnewswise.jpg

The vaccine for HPV is proving to have significant population-level effects in Connecticut, a new Yale School of Public Health study finds.

Medicine

Channels:

Radiation Therapy, Radiotherapy, Cancer, Radiation Oncology, International Journal Of Radiation Oncology Biology Physics, Bladder Cancer, Urologic Cancer, Urology

Combined Modality Treatment Could Be First Course of Treatment for Muscle-Invasive Bladder Cancer, New Study Shows

RedJournalLogo.jpg

A meta-analysis of previously published cancer research showed no difference in five-year and 10-year survival rates between patients who underwent radical cystectomy, which is the surgical removal of the bladder, and a bladder-preserving combined modality treatment (CMT) plan, which combines radiation therapy, chemotherapy and the removal of the bladder tumor.

Medicine

Channels:

glucose transporter 1, Ovarian Cancer, GLUT1, glucose transporter receptor

Unexpected Presence of Glucose Receptor in Ovarian Cancer Links Metabolism to Most Aggressive Cases

image10X.jpg

A new study of non-diabetic women with ovarian cancer reveals a potential correlation and area for further study regarding the expression of the GLUT1 glucose transporter receptor at the cancer tissue level. GLUT1 is a receptor protein involved in the absorption of glucose, or sugar, in the bloodstream and across membranes in the body.







Chat now!